Related references
Note: Only part of the references are listed.Risk of Developing Pneumonia Is Enhanced by the Combined Traits of Fluoroquinolone Resistance and Type III Secretion Virulence in Respiratory Isolates of Pseudomonas aeruginosa
Eva Sullivan et al.
CRITICAL CARE MEDICINE (2014)
The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review
M. Hatipoglu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Clinical Characteristics and Risk Factors of Diabetic Foot Ulcer With Multidrug-Resistant Organism Infection
Xiaoyan Ji et al.
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS (2014)
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections
Benjamin A. Lipsky et al.
CLINICAL INFECTIOUS DISEASES (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
A prospective, multi-center study: factors related to the management of diabetic foot infections
B. M. Ertugrul et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
ExsD Inhibits Expression of the Pseudomonas aeruginosa Type III Secretion System by Disrupting ExsA Self-Association and DNA Binding Activity
Evan D. Brutinel et al.
JOURNAL OF BACTERIOLOGY (2010)
Role of Pseudomonas aeruginosa type III effectors in disease
Joanne Engel et al.
CURRENT OPINION IN MICROBIOLOGY (2009)
Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia
Ali A. El Solh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers
J. -L. Richard et al.
DIABETES & METABOLISM (2008)
Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients with Pseudomonas aeruginosa Bacteremia
K. W. Garey et al.
JOURNAL OF CHEMOTHERAPY (2008)
Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines
Malgorzata Stepinska et al.
MICROBIAL PATHOGENESIS (2008)
Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis
C. Tascini et al.
JOURNAL OF CHEMOTHERAPY (2006)
Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of pseudomonas aeruginosa isolates associated with keratitis
H Zhu et al.
CURRENT EYE RESEARCH (2006)
Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact
V Aloush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The global burden of diabetic foot disease
AJM Boulton et al.
LANCET (2005)
Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer
N Ohmagari et al.
CANCER (2005)
Use of the Rydel-Seiffer graduated tuning fork in the assessment of vibration threshold in postherpetic neuralgia patients and healthy controls
TL Whitton et al.
EUROPEAN JOURNAL OF PAIN (2005)
Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units:: Role of antibiotics with antipseudomonal activity
E Paramythiotou et al.
CLINICAL INFECTIOUS DISEASES (2004)
Medical treatment of diabetic foot infections
BA Lipsky
CLINICAL INFECTIOUS DISEASES (2004)
V-antigen genotype and phenotype analyses of clinical isolates of Pseudomonas aeruginosa
LR Allmond et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung
CM Shaver et al.
INFECTION AND IMMUNITY (2004)
Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact
A Hartemann-Heurtier et al.
DIABETIC MEDICINE (2004)
The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer
T Kästenbauer et al.
DIABETIC MEDICINE (2004)
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections
B Cao et al.
JOURNAL OF HOSPITAL INFECTION (2004)
Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates:: Evidence for a possible association between O serotypes and exo genes
P Berthelot et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia
GS Schulert et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Epidemic population structure of Pseudomonas aeruginosa:: Evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors
JA Lomholt et al.
INFECTION AND IMMUNITY (2001)
Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?
J Ciampolini et al.
POSTGRADUATE MEDICAL JOURNAL (2000)
Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread
M Allewelt et al.
INFECTION AND IMMUNITY (2000)
Share Paper
